Cargando…
Post-COVID interstitial lung disease in symptomatic patients after COVID-19 disease
COVID-19 is often associated with long-lasting pulmonary symptoms. Data are scarce about interstitial lung disease (ILD) in patients following COVID-19 hospitalization with persistent symptoms. We retrospectively reviewed all cases sent to pulmonary post-COVID evaluation due to persistent symptoms b...
Autores principales: | Fesu, Dorottya, Polivka, Lorinc, Barczi, Eniko, Foldesi, Marcell, Horvath, Gabor, Hidvegi, Edit, Bohacs, Aniko, Muller, Veronika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037361/ https://www.ncbi.nlm.nih.gov/pubmed/36961666 http://dx.doi.org/10.1007/s10787-023-01191-3 |
Ejemplares similares
-
Remdesivir in Solid Organ Recipients for COVID-19 Pneumonia
por: Fesu, Dorottya, et al.
Publicado: (2022) -
Treatment and Systemic Sclerosis Interstitial Lung Disease Outcome: The Overweight Paradox
por: Nagy, Alexandra, et al.
Publicado: (2022) -
Clinical Predictors of Lung-Function Decline in Systemic-Sclerosis-Associated Interstitial Lung Disease Patients with Normal Spirometry
por: Nagy, Tamas, et al.
Publicado: (2022) -
Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
por: Barczi, Eniko, et al.
Publicado: (2020) -
Long-term survival benefit of male and multimorbid COVID-19 patients with 5-day remdesivir treatment
por: Polivka, Lorinc, et al.
Publicado: (2022)